References in periodicals archive ?
Pegvisomant functions as a growth hormone receptor antagonist.
Sensus' growth hormone receptor antagonist technology was licensed from Ohio University's Edison Biotechnology Center and Genentech, Inc.
SOMAVERT is the first in a new class of medicines called growth hormone receptor antagonists.

Full browser ?